【摘要】 抗乙型肝炎免疫核糖核酸联合玄驹口服液治疗乙型肝炎病毒(HBV)感染病人28例;另单用抗乙肝免疫核糖核酸治疗同样病情者27例为对照,半年之内观察乙型肝炎病毒标志物(HBVm)的影响,结果治疗组 HBeAg、HBV-DNA 阴转率分别为48.6%,42.8%;对照组分别为16.4%,0%,治疗组与对照组比较差异有高度显著性(P<0.01)。更多还原

【Abstract】 28 chronic HBV infectiou cases serving as treatment group were adminitered with anti-hep- atitis B immune ribonucleic acid (Anti-HBV IRNA) combined with Qiang Lichun oral juice.At the same time,27 eases serving as control group with the same disease were only treated with Anti-HBV IRNA.Observation of hepatitis B viral reproducible mark was performed within six months.The results were that the negative percentage of HBeAg and HBV-DNA in the treatment group was 48.6% and 42.8% respectively,while in the control group it was 16.4% and 0% re- spectively.There was a significant difference between the two groups (P<0.01).There was no side effects during the treatment.更多还原